Home / Piperacillin and Beta-Lactamase Inhibitor / Italy
IT ATC J01CR05 · updated 2 Nov 2026
Piperacillin and Beta-Lactamase Inhibitor shortage in Italy
Is there a Piperacillin and Beta-Lactamase Inhibitor shortage in Italy?
Yes. As of 2 Nov 2026, 5 Piperacillin and Beta-Lactamase Inhibitor products are reported short in Italy, the first since 1 Nov 2024. No return date has been given. Main reason: commercial decision or withdrawal.
Also short in United States, Canada, Belgium, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | PIPERACILLINA E TAZOBACTAM AUROBINDO | Eugia Pharma (Malta) Limited | 1 Nov 2024 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | PIPERACILLINA E TAZOBACTAM KABI | FRESENIUS KABI ITALIA S.R.L. | 13 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | PIPERACILLINA E TAZOBACTAM TEVA | TEVA ITALIA S.R.L. | 31 Jul 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | PIPERACILLINA/TAZOBACTAM TILLOMED | TILLOMED ITALIA SRL | 15 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | PIPERACILLINA E TAZOBACTAM SANDOZ anticipated | SANDOZ S.P.A. | 1 Dec 2026 | not given | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.